揭示ZNF384-INTS13-hnRNPC轴作为宫癌的治疗脆弱性
Juan Wang1, Shuang Liu2, Ping Li3
1Department of Obstetrics and Gynecology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Cell death & disease
|December 22, 2025
概括
整合器复合体子单元13 (INTS13) 通过促进扩散和入侵,推动子宫癌的进展. 准INTS13为宫癌提供了一个潜在的治疗策略,影响ZNF384-INTS13-hnRNPC通路.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 宫癌是一个重要的全球健康问题,有着未满足的治疗需求.
- 确定新的治疗点对于改善患者的治疗结果至关重要.
研究的目的:
- 研究整合器综合体第13子单元 (INTS13) 在宫癌进展中的作用.
- 阐明INTS13在宫癌中的功能背后的分子机制.
主要方法:
- 对癌症基因组图谱 (TCGA) 数据集和单细胞RNA测序的分析.
- 试验室研究涉及基因沉默,CRISPR/Cas9淘汰,以及原发性宫癌细胞的宫外过度表达.
- 在体内研究使用裸体小鼠的宫癌异种移植模型.
主要成果:
- 在宫癌组织中,INTS13过度表达,与晚期和低生存率相关.
- INTS13促进宫癌细胞的增殖,迁移和入侵,同时抑制细胞亡.
- ZNF384-INTS13-hnRNPC信号轴被确定为一个关键的调节途径.
结论:
- 在宫癌的进展中,INTS13起到关键的瘤基因作用.
- 针对INTS13,可能通过ZNF384-INTS13-hnRNPC轴,代表了宫癌的有希望的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
516
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
516
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


